Azhagu Madhavan | Pharmaceutical Analysis | Excellence in Research

Azhagu Madhavan | Pharmaceutical Analysis | Excellence in Research

Dr. S. Azhagu Madhavan, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Tamil Nadu, India

Dr. S. Azhagu Madhavan, M.Sc., Ph.D., is an Assistant Professor at Saveetha Medical College and Hospital, Chennai, India. His academic background spans Zoology and Biotechnology, with a focus on pharmacology, pharmacognosy, phytochemistry, and nanotechnology. His Ph.D. research explored the pharmacological effects of Costus Spicatus in diabetic rats. He has several patents, including innovations in biosensors and biodegradable products. Dr. Madhavan has contributed to high-impact journals in neuroscience, immunology, and nanobiotechnology. He is passionate about advancing natural products and nanobiotechnology for healthcare and environmental applications.

Publication Profile

Google Scholar

Education

Dr. S. Azhagu Madhavan is an accomplished academic with a strong foundation in Zoology and Biotechnology. He earned his Ph.D. in Zoology from A Veeriya Vandayar Memorial Sri Pushpam College (an autonomous institution affiliated with Bharathidasan University) in Poondi, Thanjavur, Tamil Nadu, India, from 2016 to 2020. His academic journey began with a Master’s in Zoology (2014-2016) followed by a Bachelor’s in Zoology and Biotechnology (2011-2014), both from the same esteemed institution. Dr. Madhavan’s educational background reflects his deep passion for biological sciences and commitment to advancing knowledge in his field.

Experience

Dr. S. Azhagu Madhavan has accumulated valuable experience in the academic and research fields. He is currently serving as an Assistant Professor at Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, since 2022. Previously, he worked as a Research Associate at Global Scientific Research Services, Ariyalur (2020-2021), and as a Research Assistant at Harman Institute of Science Education and Research, Thanjavur (2016-2017). With a total of 4 years and 8 months of experience, Dr. Madhavan has significantly contributed to the field of biological sciences.

Awards

Dr. S. Azhagu Madhavan has made notable contributions to the scientific community through his oral presentations. One of his significant presentations, titled “Earthworm Cut of Bacteria and Fungus Analysis Eisenia fetida,” was delivered at the National Conference on Trends in Healthcare and Biotechnology in 2016. In addition to this, he was invited as a speaker for the event Opportunities & Challenges (THBOC-2016), organized by the P.G & Department of Zoology and Biotechnology, A.V.V.M Sri Pushpam College. His ongoing efforts continue to impact the field of healthcare and biotechnology.

Research Focus

Dr. S. Azhagu Madhavan’s research primarily focuses on phytochemistry, nanotechnology, and medicinal plants. His studies include phytochemical screening, GC-MS analysis, and green synthesis of nanoparticles from various plant extracts such as Silybum marianum, Murraya koenigii, and Avicennia marina. He explores the bioactive compounds in these plants for their antioxidant, anticancer, antibacterial, and antidiabetic properties. His work on silver nanoparticles also highlights their potential applications in biomedical sciences. His contributions significantly impact areas like pharmacology and nanomedicine.

Publication Top Notes

Phytochemical screening and GC-MS analysis of bioactive compounds present in ethanolic leaves extract of Silybum marianum (L).

Potential of banana based cellulose materials for advanced applications: A review on properties and technical challenges

Green synthesis and characterization of silver nanoparticles with different solvent extracts of Sesbania grandiflora (L.) Poiret and assessment of their antibacterial …

Phytochemical screening and GC–MS analysis of bioactive compounds present in ethanolic leaf extract Murraya koenigii

Polyphenol-compounds From Green Synthesis of Antimicrobial property of Silver Nanoparticles using Eichhornia crassipes: Characterization and Applications

Phytochemical screening and comparative gc–ms analysis of bioactive compounds present in methanolic leaf and latex extract Calotropis gigantea (L)

Extraction, biosynthesis, and characterization of silver nanoparticles for its enhanced applications of antibacterial activity using the Silybum marianum Linn. plant

Identification and characterization of silver nanoparticles from Erythrina indica and its antioxidant and Uropathogenic antimicrobial properties

Anticancer activity of Pedalium murex linn methanolic leaves extract against A549 human lung cancer cell line

YORINOBU MAEDA | Drug Delivery Systems | Pharmaceutical Advancement Award

YORINOBU MAEDA | Drug Delivery Systems | Pharmaceutical Advancement Award

Prof Dr YORINOBU MAEDA, Fukuyama university, Japan

Prof. Dr. Yorinobu Maeda, Ph.D. (Hiroshima University, 1990), is a renowned expert in drug safety, pharmacokinetics, and infection control. As a professor at Fukuyama University and Drug Safety Director, he has advanced renal function-based dosing and prescription optimization. His contributions have earned him multiple awards, including Best Paper Awards (2001, 2005) and an Academic Contribution Award (2014) from the Japanese Society of Pharmaceutical Health Care and Sciences. With a strong academic and clinical impact, Dr. Maeda is a leading figure in pharmaceutical advancements, ensuring better patient safety and treatment efficacy. 🏅🔬

Publication Profile

scopus

Educational and Professional Background

Prof. Dr. Yorinobu Maeda has a distinguished background in pharmaceutical sciences, earning his Ph.D. from Hiroshima University in 1990 🎓. His expertise spans infection control, hospital pharmacy specialization, and drug safety leadership, reflecting his dedication to pharmaceutical advancements 💊. With leadership roles in major hospitals 🏥 and an esteemed position as a professor at Fukuyama University 🎓, he has made significant academic and practical contributions to the field. His work continues to shape the future of pharmacy, ensuring patient safety and advancing healthcare practices for better medical outcomes 🌍🔬.

Contributions to Pharmaceutical Sciences

Prof. Dr. Yorinobu Maeda has made significant contributions to pharmaceutical sciences, particularly in drug safety, pharmacokinetics, and dosage optimization 💊🔬. His research focuses on infection control 🦠, renal function-based dosing 🏥, and improving prescription practices, directly enhancing patient safety and treatment efficacy 👨‍⚕️✅. As a Drug Safety Director, he plays a crucial role in advancing pharmaceutical practices, ensuring medications are used effectively and safely. His dedication to optimizing drug therapy and refining medical protocols continues to have a lasting impact on healthcare, improving outcomes for patients worldwide 🌍💉.

Awards and Recognitions

Prof. Dr. Yorinobu Maeda has made remarkable contributions to the field of pharmaceutical healthcare, earning numerous prestigious accolades from the Japanese Society of Pharmaceutical Health Care and Sciences. His achievements include the Best Paper Awards in 2001 and 2005 🏆, as well as the esteemed Academic Contribution Award in 2014 🎓. These honors highlight his dedication to advancing research and implementing pharmacokinetic principles to enhance patient safety and care 🩺. Dr. Maeda’s work stands as a testament to his unwavering commitment to improving healthcare standards and fostering innovation in pharmaceutical sciences. 🌟

Research Focus

Professor Dr. Yorinobu Maeda is an eminent researcher specializing in pharmaceutical sciences, with a primary focus on drug bioavailability, prodrug development, and therapeutic drug monitoring. His work spans areas such as drug absorption, small intestinal bacterial overgrowth diagnosis, and managing adverse drug reactions. Notable research includes the impact of metal ions on drug efficacy and innovative prodrug strategies. Through collaborative studies, he contributes to optimizing drug delivery systems and clinical pharmacotherapy, enhancing patient safety and treatment outcomes. 🧪💊

Publication Top Notes

5-Aminosalicylic Acid Distribution into the Intestinal Membrane Along the Gastrointestinal Tract After Oral Administration in Rats

Development and Evaluation of EDTA-Treated Rabbits for Bioavailability Study of Chelating Drugs Using Levofloxacin, Ciprofloxacin, Hemiacetal Ester Prodrugs, and Tetracycline

Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth

Ester Prodrugs of Levofloxacin to Prevent Chelate Formation in Presence of Aluminium Ion

Study on the method to avoid infusion‑site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells

Effect of aluminium ion on bioavailability of levofloxacin following oral administration of cilexetil ester of levofloxacin as prodrug in rats